menu
    • menu

    Company profile for Galapagos

    NEW Drugs in Dev: 30
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biotechnology company, focused on the development and commercialization of novel medicines that will improve people's lives. We seek to develop a robust portfolio of clinical-stage breakthrough therapies that have the potential to re...
    Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biotechnology company, focused on the development and commercialization of novel medicines that will improve people's lives. We seek to develop a robust portfolio of clinical-stage breakthrough therapies that have the potential to revolutionize existing treatment paradigms. Our ambition is to become a leading global biotechnological company, focused on the development and commercialization of novel medicines that will improve people’s lives.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GalapagosBelgium Flag
    Country
    Country
    Belgium
    Address
    Address
    Galapagos NV Generaal De Wittelaan L11 A3 2800 Mechelen, Belgium
    Telephone
    Telephone
    +3215342900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.glpg.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biofocus/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Products Expo

    Natural Products Expo

    Not Confirmed

    envelop Contact Supplier

    Natural Products Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Galapagos Took €228M Hit From Cell Therapy Wind-Down
    Galapagos Took €228M Hit From Cell Therapy Wind-Down

    24 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/galapagos-took-eu228m-hit-cell-therapy-wind-down-still-has-cash-dealmaking

    FIERCE BIOTECH
    24 Feb 2026
    Share Share
    Galapagos Unveils 2025 Financials, Fourth Quarter Business Update
    Galapagos Unveils 2025 Financials, Fourth Quarter Business Update

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3243014/0/en/Galapagos-Reports-Full-Year-2025-Financial-Results-and-Provides-Fourth-Quarter-Business-Update.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share
    Galapagos Welcomes Dr. Paulo Fontoura To Its Board Of Directors
    Galapagos Welcomes Dr. Paulo Fontoura To Its Board Of Directors

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3241510/0/en/Galapagos-Welcomes-Dr-Paulo-Fontoura-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Galapagos Receives Transparency Notification From Bank Of America
    Galapagos Receives Transparency Notification From Bank Of America

    16 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/16/3238887/0/en/Galapagos-Receives-Transparency-Notification-from-Bank-of-America.html

    GLOBENEWSWIRE
    16 Feb 2026
    Share Share
    Galapagos Receive Transparency Notifications from Bank of America
    Galapagos Receive Transparency Notifications from Bank of America

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235759/0/en/Galapagos-Receives-Transparency-Notifications-from-Bank-of-America.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    JPM26: Galapagos' New CEO Is Here To Finally Turn The Ship Around
    JPM26: Galapagos' New CEO Is Here To Finally Turn The Ship Around

    19 Jan 2026

    // BIOSPACE

    https://www.biospace.com/business/jpm26-galapagos-new-ceo-is-here-to-finally-turn-the-ship-around

    BIOSPACE
    19 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search